Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience

Jennifer Oliveira, Lea M. Coon, Lori A. Frederick, Molly Hein, Kenneth C. Swanson, Michelle E. Savedra, Tavanna R. Porter, Mrinal M Patnaik, Ayalew Tefferi, Animesh D Pardanani, Stefan K. Grebe, David S. Viswanatha, James Hoyer

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hereditary erythrocytosis is associated with high oxygen affinity hemoglobin variants (HOAs), 2,3-bisphosphoglycerate deficiency and abnormalities in EPOR and the oxygen-sensing pathway proteins PHD, HIF2α, and VHL. Our laboratory has 40 years of experience with hemoglobin disorder testing and we have characterized HOAs using varied protein and molecular techniques including functional assessment by p50 analysis. In addition, we have more recently commenced adding the assessment of clinically relevant regions of the VHL, BPGM, EPOR, EGLN1 (PHD2), and EPAS1 (HIF2A) genes in a more comprehensive hereditary erythrocytosis panel of tests. Review of our experience confirms a wide spectrum of alterations associated with erythrocytosis which we have correlated with phenotypic and clinical features. Through generic hemoglobinopathy testing, we have identified 762 patients with 81 distinct HOA Hb variants (61 β, 20 α), including 12 that were first identified by our laboratory. Of the 1192 cases received for an evaluation specific for hereditary erythrocytosis, approximately 12% had reportable alterations: 85 pathogenic/likely pathogenic mutations and 58 variants of unknown significance. Many have not been previously reported. Correlation with clinical and phenotypic data supports an algorithmic approach to guide economical evaluation; although, testing is expanded if the suspected causes are negative or of uncertain significance. Clinical features are similar and range from asymptomatic to recurrent headaches, fatigue, restless legs, chest pain, exertional dyspnea and thrombotic episodes. Many patients were chronically phlebotomized with reported relief of symptoms.

Original languageEnglish (US)
Pages (from-to)1029-1041
Number of pages13
JournalAmerican Journal of Hematology
Volume93
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Hemoglobins
Mutation
Oxygen
2,3-Diphosphoglycerate
Restless Legs Syndrome
Hemoglobinopathies
Polycythemia
Chest Pain
Dyspnea
Fatigue
Headache
Proteins
Primary familial and congenital Polycythemia
Genes

ASJC Scopus subject areas

  • Hematology

Cite this

Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience. / Oliveira, Jennifer; Coon, Lea M.; Frederick, Lori A.; Hein, Molly; Swanson, Kenneth C.; Savedra, Michelle E.; Porter, Tavanna R.; Patnaik, Mrinal M; Tefferi, Ayalew; Pardanani, Animesh D; Grebe, Stefan K.; Viswanatha, David S.; Hoyer, James.

In: American Journal of Hematology, Vol. 93, No. 8, 01.08.2018, p. 1029-1041.

Research output: Contribution to journalArticle

Oliveira, Jennifer ; Coon, Lea M. ; Frederick, Lori A. ; Hein, Molly ; Swanson, Kenneth C. ; Savedra, Michelle E. ; Porter, Tavanna R. ; Patnaik, Mrinal M ; Tefferi, Ayalew ; Pardanani, Animesh D ; Grebe, Stefan K. ; Viswanatha, David S. ; Hoyer, James. / Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience. In: American Journal of Hematology. 2018 ; Vol. 93, No. 8. pp. 1029-1041.
@article{060cbd266d3447f6b03321cd29191923,
title = "Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience",
abstract = "Hereditary erythrocytosis is associated with high oxygen affinity hemoglobin variants (HOAs), 2,3-bisphosphoglycerate deficiency and abnormalities in EPOR and the oxygen-sensing pathway proteins PHD, HIF2α, and VHL. Our laboratory has 40 years of experience with hemoglobin disorder testing and we have characterized HOAs using varied protein and molecular techniques including functional assessment by p50 analysis. In addition, we have more recently commenced adding the assessment of clinically relevant regions of the VHL, BPGM, EPOR, EGLN1 (PHD2), and EPAS1 (HIF2A) genes in a more comprehensive hereditary erythrocytosis panel of tests. Review of our experience confirms a wide spectrum of alterations associated with erythrocytosis which we have correlated with phenotypic and clinical features. Through generic hemoglobinopathy testing, we have identified 762 patients with 81 distinct HOA Hb variants (61 β, 20 α), including 12 that were first identified by our laboratory. Of the 1192 cases received for an evaluation specific for hereditary erythrocytosis, approximately 12{\%} had reportable alterations: 85 pathogenic/likely pathogenic mutations and 58 variants of unknown significance. Many have not been previously reported. Correlation with clinical and phenotypic data supports an algorithmic approach to guide economical evaluation; although, testing is expanded if the suspected causes are negative or of uncertain significance. Clinical features are similar and range from asymptomatic to recurrent headaches, fatigue, restless legs, chest pain, exertional dyspnea and thrombotic episodes. Many patients were chronically phlebotomized with reported relief of symptoms.",
author = "Jennifer Oliveira and Coon, {Lea M.} and Frederick, {Lori A.} and Molly Hein and Swanson, {Kenneth C.} and Savedra, {Michelle E.} and Porter, {Tavanna R.} and Patnaik, {Mrinal M} and Ayalew Tefferi and Pardanani, {Animesh D} and Grebe, {Stefan K.} and Viswanatha, {David S.} and James Hoyer",
year = "2018",
month = "8",
day = "1",
doi = "10.1002/ajh.25150",
language = "English (US)",
volume = "93",
pages = "1029--1041",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience

AU - Oliveira, Jennifer

AU - Coon, Lea M.

AU - Frederick, Lori A.

AU - Hein, Molly

AU - Swanson, Kenneth C.

AU - Savedra, Michelle E.

AU - Porter, Tavanna R.

AU - Patnaik, Mrinal M

AU - Tefferi, Ayalew

AU - Pardanani, Animesh D

AU - Grebe, Stefan K.

AU - Viswanatha, David S.

AU - Hoyer, James

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Hereditary erythrocytosis is associated with high oxygen affinity hemoglobin variants (HOAs), 2,3-bisphosphoglycerate deficiency and abnormalities in EPOR and the oxygen-sensing pathway proteins PHD, HIF2α, and VHL. Our laboratory has 40 years of experience with hemoglobin disorder testing and we have characterized HOAs using varied protein and molecular techniques including functional assessment by p50 analysis. In addition, we have more recently commenced adding the assessment of clinically relevant regions of the VHL, BPGM, EPOR, EGLN1 (PHD2), and EPAS1 (HIF2A) genes in a more comprehensive hereditary erythrocytosis panel of tests. Review of our experience confirms a wide spectrum of alterations associated with erythrocytosis which we have correlated with phenotypic and clinical features. Through generic hemoglobinopathy testing, we have identified 762 patients with 81 distinct HOA Hb variants (61 β, 20 α), including 12 that were first identified by our laboratory. Of the 1192 cases received for an evaluation specific for hereditary erythrocytosis, approximately 12% had reportable alterations: 85 pathogenic/likely pathogenic mutations and 58 variants of unknown significance. Many have not been previously reported. Correlation with clinical and phenotypic data supports an algorithmic approach to guide economical evaluation; although, testing is expanded if the suspected causes are negative or of uncertain significance. Clinical features are similar and range from asymptomatic to recurrent headaches, fatigue, restless legs, chest pain, exertional dyspnea and thrombotic episodes. Many patients were chronically phlebotomized with reported relief of symptoms.

AB - Hereditary erythrocytosis is associated with high oxygen affinity hemoglobin variants (HOAs), 2,3-bisphosphoglycerate deficiency and abnormalities in EPOR and the oxygen-sensing pathway proteins PHD, HIF2α, and VHL. Our laboratory has 40 years of experience with hemoglobin disorder testing and we have characterized HOAs using varied protein and molecular techniques including functional assessment by p50 analysis. In addition, we have more recently commenced adding the assessment of clinically relevant regions of the VHL, BPGM, EPOR, EGLN1 (PHD2), and EPAS1 (HIF2A) genes in a more comprehensive hereditary erythrocytosis panel of tests. Review of our experience confirms a wide spectrum of alterations associated with erythrocytosis which we have correlated with phenotypic and clinical features. Through generic hemoglobinopathy testing, we have identified 762 patients with 81 distinct HOA Hb variants (61 β, 20 α), including 12 that were first identified by our laboratory. Of the 1192 cases received for an evaluation specific for hereditary erythrocytosis, approximately 12% had reportable alterations: 85 pathogenic/likely pathogenic mutations and 58 variants of unknown significance. Many have not been previously reported. Correlation with clinical and phenotypic data supports an algorithmic approach to guide economical evaluation; although, testing is expanded if the suspected causes are negative or of uncertain significance. Clinical features are similar and range from asymptomatic to recurrent headaches, fatigue, restless legs, chest pain, exertional dyspnea and thrombotic episodes. Many patients were chronically phlebotomized with reported relief of symptoms.

UR - http://www.scopus.com/inward/record.url?scp=85051743204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051743204&partnerID=8YFLogxK

U2 - 10.1002/ajh.25150

DO - 10.1002/ajh.25150

M3 - Article

AN - SCOPUS:85051743204

VL - 93

SP - 1029

EP - 1041

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 8

ER -